Description
The Sovicell TRANSIL AGP Binding Kit enables researchers to predict the affinity of drugs to α1-acid glycoprotein which helps to assess the variability of plasma protein binding under various physiological and disease conditions. In conjunction with the TRANSIL HSA Binding Kit good predictions of total plasma protein binding are possible. The innovative TRANSIL binding assays are in vitro kits enabling the researcher to predict the fraction bound to plasma proteins in a highly defined and pH stable assay system.
Additional information
| Weight |
22.4 oz |
| Dimensions |
11.2 × 4.6 × 6.2 in |
| Unit Quantity |
96 well, 240 ul
|
| Shipping Temperature |
+4C
|
| Storage Temperature |
-20C
|
For research use only. not for diagnostic use.
Citations
Interaction of pharmaceutical metabolites with blood proteins and membrane lipids in the view of bioconcentration: A preliminary study based on in vitro assessmentAuthors: Kowalska, Dorota, et al.
Science of the Total Environment 783 (2021)
In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer’s DiseaseAuthors: Schartmann, Elena, et al.
Journal of Alzheimer's disease 64.3 (2018): 859-873
Comparison of blood-brain barrier penetration efficiencies between linear and cyclic all-d-enantiomeric peptides developed for the treatment of Alzheimer's diseaseAuthors: Schartmann, Elena, et al.
European journal of pharmaceutical sciences 114 (2018): 93-102
Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s DiseaseAuthors: Jiang, Nan, et al.
PloS one 10.6 (2015): e0128553
High-Throughput 1,536-Well Fluorescence Polarization Assays for α1-Acid Glycoprotein and Human Serum Albumin BindingAuthors: Yasgar, Adam, et al.
PLoS One. 2012;7(9):e45594
